MIAMI, Feb. 24 /PRNewswire/ -- VITAS Innovative Hospice Care(R) announced
today that Christopher Rieder has been named senior vice president and chief
information officer. In his new position, Rieder will oversee planning and
implementation of IT operations throughout VITAS to support the company's
Rieder has more than 20 years of IT experience with global organizations
translating business objectives into technology solutions. He has worked
extensively with pharmaceutical and biotechnology companies.
Rieder most recently was chief information officer and vice president at
Parexel, Inc., a leading bio-pharmaceutical services organization. At Parexel,
Rieder led the company's worldwide technology initiatives, including
integration of technology solutions, information management and business
processes. Prior to that position, Rieder served as vice president of
information technology for Kos Pharmaceuticals, where he built a customer-
centric IT division to improve the company's customer service operations.
"Chris's experience at the senior management level will make him a superb
asset to our organization," said David Wester, VITAS president and chief
financial officer. "His ability to bring a working knowledge of technology to
corporate initiatives will help us continue to offer innovative solutions for
providing exceptional end-of-life care to our patients and their families."
Rieder holds an MBA in information technology from American University in
Washington, D.C., and a BSBA in business economics and pre-medicine from the
University of Arizona. A member of the Society for Information Management,
Rieder was a contributing author of the book, "Improving Technology ROI:
Leading CTOs and CIOs on Making Successful Technology Investments, Maximizing
Return on Investments, & Gaining a Competitive Edge (Inside the Minds)."
Page: 1 2 Related biology technology :1
|SOURCE VITAS Innovative Hospice Care(R)|
Copyright©2009 PR Newswire.
All rights reserved
. Navitas Names Dr. Dean Gesme as Medical Director2
. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children3
. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System4
. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility5
. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial6
. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features7
. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia8
. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug9
. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis10
. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer11
. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC